川崎病201例回顾性分析

Han R K,Silverman E D,Newman A,et al.Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease.Arch Pediatr Adolesc Med,2000,154:694-699.

Fong N C,Hui Y W,Li C K,et al.Evaluation of the efficacy of treatment of Kawasaki disease before day 5 of illness.Pediatr Cardiol,2004,25:31-34.

龚方戚,白石裕比湖,桃并真理子.川崎病患儿冠状动脉病变的随访及超声与造影的对照研究.中华儿科杂志,2000,38:634.

Cheung Y F,Yung T C,Tam S C,et al.Novel and traditional cardiovascular risk factors in children after Kawasaki disease:implications for premature atherosclerosis.J Am Coil Cardiol,2004,43:120-124.

Noto N,Okada T,Yamasuge M,et al.Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions.Pediatrics,2001,107:1095-1099.

Silva A A,Macao Y,Hashmi A,et al.Cardiovascular risk factors after Kawasaki disease:a case-control study.J Pediatr,2001,138:400-405.

Miura M,Ohki H,Tsuchihashi T,et al.Coronary risk factors in Kawasaki disease treated with additional gammaglobulin.Arch Dis Child,2004,89:776-780.

Newburger J W,Takahashi M,Gerber M A,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever,Endocarditis,and Kawasaki Disease,Council on Cardiovascular Disease in the Young,American Heart Association.Pediatrics,2004,114:1708-1733.

>>更多...

Clinical analysis of 201 patients with Kawasaki disease:what are the high risk factors